# MPM Bioimpact LLC 13F holdings Q2 2026: $1.6 billion

MPM Bioimpact LLC reported $1.6 billion in 13F securities across 37 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Cullinan Therapeutics Inc at $177 million, 10.8% of the reported value. Since Q1 2026 it opened 7 new positions and exited 11.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $1,639,957,110
- Positions: 37
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1687078
- Form 13F file number: 028-20107
- CRD number: 309865
- Business address: 399 Boylston Street, Suite 1100, Boston, MA 02116
- SEC filing: [0001193125-26-352199](https://www.sec.gov/Archives/edgar/data/1687078/000119312526352199/0001193125-26-352199-index.htm)

## Top 25 holdings by value

The largest of 37 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Cullinan Therapeutics Inc](https://specstream.ai/data/institutional-holders/cullinan-therapeutics-inc-230031106) | COM | 9,731,341 | $177.2 million | +2,083,073 |
| [Aktis Oncology Inc](https://specstream.ai/data/institutional-holders/aktis-oncology-inc-01021m104) | COM | 4,835,872 | $155.9 million | No change |
| [Liquidia Corporation](https://specstream.ai/data/institutional-holders/liquidia-corporation-53635d202) | COM NEW | 1,386,174 | $110.5 million | -18,984 |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 492,483 | $92.2 million | -14,293 |
| [Corcept Therapeutics Inc](https://specstream.ai/data/institutional-holders/corcept-therapeutics-inc-218352102) | COM | 771,028 | $67 million | -214,672 |
| [Edgewise Therapeutics Inc](https://specstream.ai/data/institutional-holders/edgewise-therapeutics-inc-28036f105) | COM | 1,620,780 | $65.9 million | -39,916 |
| [Travere Therapeutics Inc](https://specstream.ai/data/institutional-holders/travere-therapeutics-inc-89422g107) | COM | 1,122,731 | $63.8 million | -10,634 |
| [DBV Technologies S a](https://specstream.ai/data/institutional-holders/dbv-technologies-s-a-23306j309) | SPONSORED ADS | 3,666,284 | $60.1 million | -1,547,077 |
| [Trevi Therapeutics Inc](https://specstream.ai/data/institutional-holders/trevi-therapeutics-inc-89532m101) | COM | 3,073,577 | $57.3 million | -224,853 |
| [Alumis Inc](https://specstream.ai/data/institutional-holders/alumis-inc-022307102) | COM | 2,019,020 | $56.8 million | -367,509 |
| [Uniqure NV](https://specstream.ai/data/institutional-holders/uniqure-nv-n90064101) | SHS | 1,225,855 | $56.5 million | -143,376 |
| [Ultragenyx Pharmaceutical in](https://specstream.ai/data/institutional-holders/ultragenyx-pharmaceutical-in-90400d108) | COM | 1,418,215 | $47.4 million | New |
| [Relay Therapeutics Inc](https://specstream.ai/data/institutional-holders/relay-therapeutics-inc-75943r102) | COM | 2,415,672 | $45.2 million | +56,086 |
| [Abivax SA](https://specstream.ai/data/institutional-holders/abivax-sa-00370m103) | SPONSORED ADS | 336,347 | $44.8 million | +229,079 |
| [Dyne Therapeutics Inc](https://specstream.ai/data/institutional-holders/dyne-therapeutics-inc-26818m108) | COM | 1,922,093 | $42.7 million | +513,941 |
| [Dianthus Therapeutics Inc](https://specstream.ai/data/institutional-holders/dianthus-therapeutics-inc-252828108) | COM | 420,002 | $40.9 million | -3,980 |
| [Bioage Labs Inc](https://specstream.ai/data/institutional-holders/bioage-labs-inc-09077v100) | COM | 1,667,661 | $40.9 million | New |
| [Urogen Pharma LTD](https://specstream.ai/data/institutional-holders/urogen-pharma-ltd-m96088105) | COM | 933,415 | $34.3 million | -10,388 |
| [Moonlake Immunotherapeutics](https://specstream.ai/data/institutional-holders/moonlake-immunotherapeutics-61559x104) | CLASS A ORD | 1,606,967 | $31.3 million | -204,115 |
| [Palvella Therapeutics Inc Ne](https://specstream.ai/data/institutional-holders/palvella-therapeutics-inc-ne-697947109) | COM | 204,027 | $31.2 million | -2,377 |
| [Taysha Gene Therapies Inc](https://specstream.ai/data/institutional-holders/taysha-gene-therapies-inc-877619106) | COM SHS | 4,500,000 | $30.6 million | New |
| [Syndax Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/syndax-pharmaceuticals-inc-87164f105) | COM | 1,333,523 | $29.2 million | -7,210 |
| [Monte Rosa Therapeutics Inc](https://specstream.ai/data/institutional-holders/monte-rosa-therapeutics-inc-61225m102) | COM | 1,161,081 | $28.1 million | -15,847 |
| [Zura Bio LTD](https://specstream.ai/data/institutional-holders/zura-bio-ltd-g9ty5a101) | CLASS A ORD SHS | 4,472,843 | $26.4 million | New |
| [Natera Inc](https://specstream.ai/data/institutional-holders/natera-inc-632307104) | COM | 92,638 | $25.1 million | -436 |

## New positions in Q2 2026

7 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Ultragenyx Pharmaceutical in](https://specstream.ai/data/institutional-holders/ultragenyx-pharmaceutical-in-90400d108) | COM | 1,418,215 | $47.4 million |
| [Bioage Labs Inc](https://specstream.ai/data/institutional-holders/bioage-labs-inc-09077v100) | COM | 1,667,661 | $40.9 million |
| [Taysha Gene Therapies Inc](https://specstream.ai/data/institutional-holders/taysha-gene-therapies-inc-877619106) | COM SHS | 4,500,000 | $30.6 million |
| [Zura Bio LTD](https://specstream.ai/data/institutional-holders/zura-bio-ltd-g9ty5a101) | CLASS A ORD SHS | 4,472,843 | $26.4 million |
| [Adlai Nortye LTD](https://specstream.ai/data/institutional-holders/adlai-nortye-ltd-00704r109) | SPONSORED ADS | 1,936,291 | $22.3 million |
| [Annexon Inc](https://specstream.ai/data/institutional-holders/annexon-inc-03589w102) | COM | 3,544,354 | $20.2 million |
| [Entrada Therapeutics Inc](https://specstream.ai/data/institutional-holders/entrada-therapeutics-inc-29384c108) | COM | 1,253,053 | $9.2 million |

## Positions exited in Q2 2026

11 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Agios Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/agios-pharmaceuticals-inc-00847x104) | COM | 1,306,261 | $44.2 million |
| [Xenon Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/xenon-pharmaceuticals-inc-98420n105) | COM | 588,706 | $34.2 million |
| [Evommune Inc](https://specstream.ai/data/institutional-holders/evommune-inc-30054y107) | COM SHS | 1,455,863 | $33.5 million |
| [Cytokinetics Inc](https://specstream.ai/data/institutional-holders/cytokinetics-inc-23282w605) | COM NEW | 500,000 | $33 million |
| [Corvus Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/corvus-pharmaceuticals-inc-221015100) | COM | 1,674,875 | $24.5 million |
| [Climb Bio Inc](https://specstream.ai/data/institutional-holders/climb-bio-inc-28658r106) | COM | 2,593,439 | $17.8 million |
| [Arcutis Biotherapeutics Inc](https://specstream.ai/data/institutional-holders/arcutis-biotherapeutics-inc-03969k108) | COM | 733,966 | $17.3 million |
| [Zymeworks Inc](https://specstream.ai/data/institutional-holders/zymeworks-inc-98985y108) | COM | 565,249 | $14.2 million |
| [Viridian Therapeutics Inc](https://specstream.ai/data/institutional-holders/viridian-therapeutics-inc-92790c104) | COM | 649,873 | $12.7 million |
| Engene Holdings Inc | COM | 1,845,373 | $12.6 million |
| [Allogene Therapeutics Inc](https://specstream.ai/data/institutional-holders/allogene-therapeutics-inc-019770106) | COM | 2,242,933 | $5.5 million |

## Also on SpecStream

- [MPM Bioimpact LLC Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1687078/000119312526352199/0001193125-26-352199-index.htm)
- [Largest 13F filers in Massachusetts](https://specstream.ai/data/institutional-holdings/state/massachusetts)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Boston, Massachusetts

- [Japanese restaurants in Boston, Massachusetts](https://specstream.ai/data/businesses/japanese-restaurants/boston-massachusetts-united-states)
- [Divorce and family law firms in Boston, Massachusetts](https://specstream.ai/data/businesses/divorce-and-family-law-firms/boston-massachusetts-united-states)
- [Architectural design firms in Boston, Massachusetts](https://specstream.ai/data/businesses/architectural-design-firms/boston-massachusetts-united-states)
- [Preschools in Boston, Massachusetts](https://specstream.ai/data/businesses/preschools/boston-massachusetts-united-states)
- [Insurance agencies in Boston, Massachusetts](https://specstream.ai/data/businesses/insurance-agencies/boston-massachusetts-united-states)
- [Commercial real estate firms in Boston, Massachusetts](https://specstream.ai/data/businesses/commercial-real-estate-firms/boston-massachusetts-united-states)
